These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 34889373

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Red cell alloimmunization in multi-transfused patients with sickle cell anemia in Benin City, Nigeria.
    Ugwu NI, Awodu OA, Bazuaye GN, Okoye AE.
    Niger J Clin Pract; 2015; 18(4):522-6. PubMed ID: 25966726
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Immuno-hematological findings in Delayed Hemolytic Transfusion Reaction (DHTR).
    Thonier V.
    Transfus Clin Biol; 2019 May; 26(2):102-108. PubMed ID: 30885514
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
    Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B.
    N Engl J Med; 1990 Jun 07; 322(23):1617-21. PubMed ID: 2342522
    [Abstract] [Full Text] [Related]

  • 51. Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis.
    Godfrey GJ, Lockwood W, Kong M, Bertolone S, Raj A.
    Pediatr Blood Cancer; 2010 Dec 01; 55(6):1134-7. PubMed ID: 20979172
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database.
    Karafin MS, Westlake M, Hauser RG, Tormey CA, Norris PJ, Roubinian NH, Wu Y, Triulzi DJ, Kleinman S, Hendrickson JE, NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).
    Br J Haematol; 2018 Jun 01; 181(5):672-681. PubMed ID: 29675950
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. The future of red blood cell alloimmunization risk reduction.
    Kacker S, Ness PM, Shirey RS, Savage WJ, King KE, Tobian AA.
    Transfusion; 2015 Jan 01; 55(1):222-4. PubMed ID: 25582240
    [No Abstract] [Full Text] [Related]

  • 57. The future of red blood cell alloimmunization risk reduction.
    Karafin MS, Denomme GA, Bryant BJ.
    Transfusion; 2015 Jan 01; 55(1):220-1. PubMed ID: 25582238
    [No Abstract] [Full Text] [Related]

  • 58. Preventing alloimmunization using a new model for matching extensively typed red blood cells.
    van de Weem RHG, Wemelsfelder ML, Luken JS, de Haas M, Niessen RWLM, van der Schoot CE, Hoogeveen H, Janssen MP.
    Vox Sang; 2022 Apr 01; 117(4):580-586. PubMed ID: 34725840
    [Abstract] [Full Text] [Related]

  • 59. Case reports: delayed hemolytic transfusion reaction in sickle cell disease.
    Syed SK, Sears DA, Werch JB, Udden MM, Milam JD.
    Am J Med Sci; 1996 Oct 01; 312(4):175-81. PubMed ID: 8853066
    [Abstract] [Full Text] [Related]

  • 60. Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment.
    Pirenne F, Bartolucci P, Habibi A.
    Transfus Clin Biol; 2017 Sep 01; 24(3):227-231. PubMed ID: 28669521
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.